Patent · US Active

Adjuvant composition, vaccine composition containing the same, and method for producing both of them

US11000586B2 · kind B2 · utility

1Cited by
2References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 28, 2018
Grant dateMay 11, 2021
Priority date
Expiry dateNov 28, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55572
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An adjuvant composition includes a pH-sensitive carrier and a substance with stimulus to activate innate immune system. The adjuvant composition serves as a carrier which is highly safe and capable of efficient induction of CTL.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.